XML 70 R59.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY (DEFICIT) (Series A Senior Preferred Stock) (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Aug. 28, 2017
Jun. 29, 2017
Mar. 31, 2016
Sep. 30, 2017
Sep. 30, 2017
Sep. 30, 2016
Jun. 13, 2017
Dec. 31, 2016
Jun. 30, 2016
Class of Stock [Line Items]                  
Preferred stock, shares authorized (in shares)       15,000,000 15,000,000     1,294,434  
Preferred stock, par value (in dollars per share)       $ 0.01 $ 0.01     $ 0.01  
Preferred stock, dividend rate (percentage)     8.00%            
Shares converted, value   $ 3,000,000     $ 0 $ 433,000      
Warrants, fair value   211,000   $ 211,000 211,000       $ 1,421,738
Issuance of preferred stock         $ 5,380,000        
Preferred stock, shares outstanding (in shares)       3,641 3,641     780,105  
Private Placement                  
Class of Stock [Line Items]                  
Consideration received   $ 400,000              
Transgenomics                  
Class of Stock [Line Items]                  
Preferred stock, dividend rate (percentage)   8.00%              
Conversion of debt into stock   $ 3,000,000              
Preferred stock - series A senior                  
Class of Stock [Line Items]                  
Preferred stock, shares authorized (in shares)   4,100,000              
Preferred stock, par value (in dollars per share)   $ 0.01              
Conversion price (in dollars per share)       $ 3.736329 $ 3.736329        
Conversion of stock, discount rate       15.00% 15.00%        
Preferred stock, dividend rate (percentage)         8.00%        
New shares issued (in shares) 22,518                
Deemed dividend         $ 5,200,000        
Number of shares converted (in shares) 1,712,901                
Convertible preferred stock, issued upon conversion (in shares) 1                
Warrants, fair value $ 1,400,000                
Issuance of preferred stock $ 84,000                
Preferred stock, shares outstanding (in shares)       0 0        
Preferred stock                  
Class of Stock [Line Items]                  
Number of shares converted from debt instrument (in shares)   802,920              
Preferred stock | Private Placement                  
Class of Stock [Line Items]                  
New shares issued (in shares)   107,056              
Preferred stock | Transgenomics                  
Class of Stock [Line Items]                  
Number of shares converted from debt instrument (in shares)   802,925              
Number of shares converted (in shares)   7,155              
Common Stock                  
Class of Stock [Line Items]                  
Conversion price (in dollars per share)             $ 10.2502    
New shares issued (in shares)   200,081              
Number of shares converted (in shares) 1,735,419 7,356,170   943,600 943,600        
Convertible preferred stock, issued upon conversion (in shares) 1                
Stock rights issued (in shares) 856,446                
Common Stock | Transgenomics                  
Class of Stock [Line Items]                  
Number of shares converted from debt instrument (in shares)   352,630